BÂRRX Medical

Pioneering endoscopic procedures for Barrett's esophagus

BARRX was a medical device company focusing on developing and commercializing a new solution to treat Barrett's esophagus. Barrett's is a pre-cancerous condition caused by GERD, and BARRX developed a novel radiofrequency ablation approach to remove diseased tissue and allow regrowth of normal cells. BARRX was acquired by Covidien in 2012.

Status

Acquired by Covidien in 2012

Year of Investment

2004

Strategy

Other

Location

Sunnyvale, California

Frazier Team